Analyst Ratings For NASDAQ:VTL – Vital Therapies (NASDAQ:VTL)
Today, BTIG Research reiterated its Hold rating on NASDAQ:VTL – Vital Therapies (NASDAQ:VTL).
Some recent analyst ratings include
- 5/28/2018-BTIG Research Reiterated Rating of Hold.
- 12/5/2017-Raymond James Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:VTL – Vital Therapies (NASDAQ:VTL)
NASDAQ:VTL – Vital Therapies (NASDAQ:VTL) has insider ownership of 33.90% and institutional ownership of 28.20%.
- On 12/13/2017 Muneer A Satter, Director, bought 100,000 with an average share price of $5.48 per share and the total transaction amounting to $548,000.00.
- On 12/11/2017 Muneer A Satter, Director, bought 150,000 with an average share price of $4.89 per share and the total transaction amounting to $733,500.00.
- On 12/7/2017 Muneer A Satter, Director, bought 50,000 with an average share price of $4.77 per share and the total transaction amounting to $238,500.00.
- On 9/14/2017 Muneer A Satter, Director, bought 130,000 with an average share price of $4.01 per share and the total transaction amounting to $521,300.00.
- On 9/13/2017 Jean Jacques Bienaime, Director, bought 10,000 with an average share price of $4.00 per share and the total transaction amounting to $40,000.00.
- On 9/8/2017 Muneer A Satter, Director, bought 50,000 with an average share price of $3.53 per share and the total transaction amounting to $176,500.00.
- On 6/14/2017 John Michael Dunn, General Counsel, bought 2,500 with an average share price of $3.09 per share and the total transaction amounting to $7,725.00.
Recent Trading Activity for NASDAQ:VTL – Vital Therapies (NASDAQ:VTL)
Shares of NASDAQ:VTL – Vital Therapies closed the previous trading session at 5.70 down -0.45 7.32% with 6.099999904632568 shares trading hands.